Prognostic Stage III Breast Cancer AJCC v8 Completed Phase 1 Trials for Alpelisib (DB12015)

Also known as: Prognostic Stage 3 Breast Cancer AJCC v8

IndicationStatusPhase
DBCOND0109635 (Prognostic Stage III Breast Cancer AJCC v8)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03207529Alpelisib and Enzalutamide in Treating Patients With Androgen Receptor and PTEN Positive Metastatic Breast CancerTreatment